Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of ...
The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients ...
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for ...
The Food and Drug Administration (FDA) has approved Itovebi (inavolisib) with Ibrance (palbociclib) and Faslodex (fulvestrant) for certain patients with advanced or metastatic breast cancer. The Food ...
US Royal Honey sells sachets of infused honey that the company claims can boost "vitality and stamina." The FDA did not list which exact products contained the erectile dysfunction medication ...
SentryBond technology could potentially extend to other medications, though FDA approval is pending. The FDA has approved oxycodone hydrochloride (RoxyBond) for the management of severe pain when ...
Live Science on MSN1mon
At-home flu vaccine approved by FDA — what to knowA nasal spray version of the annual flu vaccine can now be taken at home, the U.S. Food and Drug Administration (FDA) says.
The US Food and Drug Administration (FDA) has approved AbbVie's VYALEV (foscarbidopa and foslevodopa) to treat motor fluctuations in adults with advanced Parkinson's disease (PD). The chronic ...
The trials presented in the application for FDA approval of Enovid as an oral contraceptive were the largest drug trials ever run. In the trials, 897 women had taken 10,427 cycles of the Pill with ...
The product is expected to be available in the first half of 2025. The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab ...
Benzinga on MSN3mon
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney DiseaseOn Thursday, the FDA granted accelerated approval to Novartis AG’s (NYSE:NVS) Fabhalta (iptacopan), a first-in-class ...
11 (UPI) --Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ... issued by Pfizer. FDA scientists said the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback